JPET Data Acquisition and Analysis Systems for the Life Sciences

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 6, 2006; DOI: 10.1124/jpet.106.106526


0022-3565/06/3183-974-981$20.00
JPET 318:974-981, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.106526v1
318/3/974    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prinster, S. C.
Right arrow Articles by Hall, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prinster, S. C.
Right arrow Articles by Hall, R. A.

CELLULAR AND MOLECULAR

{alpha}2C-Adrenergic Receptors Exhibit Enhanced Surface Expression and Signaling upon Association with beta2-Adrenergic Receptors

Steven C. Prinster1, Tomas G. Holmqvist, and Randy A. Hall

Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia

The {alpha}2C-adrenergic receptor ({alpha}2CAR) is known to be poorly trafficked to the cell surface when expressed in a variety of cell types. We tested the hypothesis that the surface expression and signaling of {alpha}2CAR might be enhanced by heterodimerization with other G protein-coupled receptors (GPCRs). Cotransfection of {alpha}2CAR with more than 25 related GPCRs revealed that only coexpression with the beta2-adrenergic receptor (beta2AR) increased the surface localization of {alpha}2CAR in human embryonic kidney-293 cells. Coimmunoprecipitation of {alpha}2CAR with beta2AR confirmed a physical interaction between the two receptors. Confocal microscopy studies demonstrated that {alpha}2CAR expressed alone was mainly intracellular, whereas {alpha}2CAR coexpressed with beta2AR was predominantly localized to the plasma membrane. Ligand binding studies revealed a significant increase in {alpha}2CAR binding sites upon coexpression with beta2AR, with no apparent change in affinity for {alpha}2AR ligands. Functional assays with the {alpha}2AR-specific agonist brimonidine (UK 14,304) revealed that coexpression of beta2AR with {alpha}2CAR enhanced {alpha}2CAR-mediated activation of extracellular signal-regulated kinase 1/2. Furthermore, analyses of agonist-promoted receptor endocytosis demonstrated enhanced {alpha}2CAR internalization in response to {alpha}2AR agonists when {alpha}2CAR and beta2AR were coexpressed. In addition, substantial cointernalization of {alpha}2CAR in response to betaAR agonists was observed when {alpha}2CAR was coexpressed with beta2AR. These data reveal that {alpha}2CAR can interact with beta2AR in cells in a manner that regulates {alpha}2CAR surface expression, internalization, and functionality.


Received April 19, 2006; accepted June 2, 2006.

Address correspondence to: Dr. Randy A. Hall, Department of Pharmacology, Emory University School of Medicine, 5113 Rollins Research Center, 1510 Clifton Rd., Atlanta, GA 30322. E-mail: rhall{at}pharm.emory.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. F. Bush, S. V. Jones, A. N. Lyle, K. P. Minneman, K. J. Ressler, and R. A. Hall
Specificity of Olfactory Receptor Interactions with Other G Protein-coupled Receptors
J. Biol. Chem., June 29, 2007; 282(26): 19042 - 19051.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Salim, K. M. Standifer, and D. C. Eikenburg
Extracellular Signal-Regulated Kinase 1/2-Mediated Transcriptional Regulation of G-Protein-Coupled Receptor Kinase 3 Expression in Neuronal Cells
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 51 - 59.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.